Definitive Contract 75N92019C00005

Award Date 4/25/19
Potential Completion Date 7/25/24
Potential Value $666K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Time and Materials
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Cost Plus Fixed Fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific. The $18,792,842.54 contract is for the Immune Tolerance Network - Clinical Site Monitoring Group, which involves comprehensive clinical trial and research support services such as regulatory affairs, clinical site monitoring,...
This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to PPD Development LP, a global contract research organization (CRO). The contract, valued at $66,339,562.95, is for the TAS::75 0885::TAS NIAID DAIT CLINICAL SITE MONITORING CENTER and has a performance period ending on February 23, 2023. PPD Development LP, a subsidiary of Thermo Fisher...
This is a federal contract award to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services. The contract, valued at $139,861,060.22, is for NIAID Clinical Site Monitoring services. This is a definitive contract with a cost-plus-fixed-fee pricing type, with a period of performance through January 31, 2024. The...
This is a $28,578,960 definitive, cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific. The contract is for clinical site monitoring services in support of NIAID's various clinical research programs, trials, and studies. It has a 10-year period of performance and was awarded on a full and open basis without a set-aside designation. The...
This is a $1,737,262.53 task order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to PPD Development LP, a global contract research organization (CRO). The task order is for Phase I clinical trials in the development of neurotherapeutics and is part of the larger "Phase I Clinical Trials for Development of Neurotherapeutics" indefinite delivery/indefinite quantity (ID/IQ) contract....
This is a cost-plus-award-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to PPD Development LP, a global contract research organization (CRO). The contract, titled "NIAID HIV and Other Infectious Diseases Clinical Research Support Services (CRSS)", has a ceiling value of $342,278,815.66 and a period of performance ending on August 15, 2024. The contract was awarded...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $500,263.64 Delivery Order contract to PPD Development LP, a global contract research organization (CRO), for clinical site and study monitoring services in support of research partnerships for global mental health. The contract has a period of performance from September 28, 2018 to September 27, 2023 and is a labor hours type contract. PPD Development LP has provided over $500...
This is a $5,758,524.34 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to PPD Development LP, a global contract research organization (CRO). The contract is to provide monitoring services for a Phase III clinical trial, specifically trial A5300B/PHOENIX. It is a cost-plus-fixed-fee contract with an ultimate completion date of December 14, 2025. The contract was awarded on April 15, 2019 and is not...
This is a $75,173,993.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract provides comprehensive and rapid response services for NIAID's research programs related to HIV and other infectious diseases. This order falls under a larger $545 million Comprehensive and Rapid Response contract vehicle that...
This contract, awarded by the National Institute of Mental Health (NIMH) to PPD Development LP, a global contract research organization and subsidiary of Thermo Fisher Scientific, provides clinical research and study monitoring support services for NIMH-funded clinical trials. The contract has a ceiling value of $1,226,376.00 and a period of performance from September 28, 2022 to May 15, 2025. It is a definitive, time and materials contract with no set-aside designation. The contractor will...

This is a $666,052.25 Time and Materials contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a part of the National Institutes of Health (NIH), to PPD Development LP, a global contract research organization. The contract is for clinical site and study monitoring support services for the NHLBI's Hypertension Outcomes for T4 Research within Lower Middle-Income Countries (HY-TREC) program. The contract was awarded on April 25, 2019 with a completion date of July 25, 2024. The original contract opportunity was posted on November 19, 2018 and did not use a set-aside designation. PPD Development LP is a subsidiary of Thermo Fisher Scientific and has been awarded multiple federal contracts and grants, including a $64 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) for a Transplantation Statistical and Clinical Coordinating Center.

Generated 7/1/25, 5:13 AM